R&D channel feed – Endpoints News

R&D channel feed

Novartis touts more late-stage data for inclisiran, the once-centerpiece heart drug spurned by the FDA

4 years ago

Cortexyme lowers dose amid safety concerns, raising questions about future of offbeat Alzheimer’s approach

4 years ago

Adaptimmune says it's (nearly) ready to head to the FDA with TCR cancer therapy

4 years ago

Scoop: Famed cancer researcher — and biotech founder — Lew Cantley is headed to Dana-Farber

4 years ago

Roche, AC Immune attempt to flesh out anti-tau Alzheimer's data, but the forecast remains cloudy

4 years ago

Months after a Merck spinout, Organon continues its string of deals with a $954M buyout package

4 years ago

On the heels of solid tumor data and with competitors surging, Poseida scraps autologous CAR-T in favor of allo

4 years ago

Immatics unveils promising, early-stage data for a top contender in the race to develop TCRs. Now it has to live up to expectations

4 years ago

Novartis washes its hands of another bispecific at the center of $2.5B Xencor deal

4 years ago

Looking to get ahead in a packed migraine market, Amgen touts head-to-head data for Aimovig

4 years ago

Mirati sees more responses for KRAS drug in Keytruda combo as it angles for an edge over Amgen

4 years ago

Bristol Myers adds to neoadjuvant win for Opdivo in lung cancer, escalating early cancer showdown with Merck

4 years ago

Steering clear of FibroGen/AstraZeneca wreckage, GlaxoSmithKline spotlights pivotal data for star anemia drug

4 years ago

Mixed court decisions for Novartis in DC and Sanofi, Novo Nordisk in NJ further complicate whose interpretation of 340B is correct

4 years ago

Deciphera's TKI drug flops key test in earlier-line GI tumors, sending stock into a tailspin

4 years ago

Breaking: Pfizer's Covid-19 antiviral reduces hospitalizations by 89%, could prove a formidable foe for Merck's pill

4 years ago

Chimerix unrolls early win for glioma drug picked up earlier this year in acquisition

4 years ago

In wake of Covid-19 vaccine successes, Moderna scraps an mRNA-based antibody for chikungunya virus

4 years ago

PlateletBio announces $75.5M Series B to extend autoimmune cell therapy

4 years ago

More than a year after trimming R&D unit, Ironwood adds a rare disease drug to the pipeline in hopeful step forward

4 years ago

Sage changes primary endpoint in key study months after analysts fret about depression drug's durability

4 years ago

Amgen spotlights preclinical 'multi-specifics' as analyst predicts late-stage M&A

4 years ago

Clene's mid-stage ALS drug hits a brick wall, but can an 'efficacy signal' save the day?

4 years ago

Dems resurrect a scaled back plan for Medicare drug price negotiations

4 years ago

First page Previous page 154 155 156157158 159 160 Next page Last page